» Authors » Bruce M Camitta

Bruce M Camitta

Explore the profile of Bruce M Camitta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 3705
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Escherich C, Chen W, Li Y, Yang W, Nishii R, Li Z, et al.
Blood . 2024 Mar; 143(22):2270-2283. PMID: 38446568
Biallelic mutation in the DNA-damage repair gene NBN is the genetic cause of Nijmegen breakage syndrome, which is associated with predisposition to lymphoid malignancies. Heterozygous carriers of germ line NBN...
2.
Escherich C, Chen W, Li Y, Yang W, Nishii R, Li Z, et al.
Res Sq . 2023 Jul; PMID: 37503171
Biallelic mutation in the DNA-damage repair gene is the genetic cause of Nijmegen Breakage Syndrome, which is associated with predisposition to lymphoid malignancies. Heterozygous carriers of germline variants may also...
3.
4.
Hopp A, Tetzlaff J, Kopidlansky K, Leventaki V, Parsons L, Bone K, et al.
Am J Clin Pathol . 2022 Jan; 158(1):81-95. PMID: 35050350
Objectives: Partnerships between low- to middle-income countries (LMICs) and high-income countries (HICs) is one strategy to mitigate observed health disparities. Cambodia's Angkor Hospital for Children (AHC), an LMIC institution, faces...
5.
Lyvannak S, Sreynich K, Heng S, Nara L, Farrilend P, Camitta B
J Pediatr Hematol Oncol . 2021 May; 43(5):201-202. PMID: 34001786
No abstract available.
6.
Khauv P, Sreynich K, Lyvannak S, Camitta B
J Pediatr Hematol Oncol . 2021 May; 43(5):200. PMID: 34001780
No abstract available.
7.
Winick N, Martin P, Devidas M, Shuster J, Borowitz M, Bowman W, et al.
Leukemia . 2019 Nov; 34(4):1006-1016. PMID: 31728054
The delayed intensification (DI) enhanced outcome for patients with acute lymphoblastic leukemia (ALL) treated on BFM 76/79 and CCG 105 after a prednisone-based induction. Childrens Oncology Group protocols P9904/9905 evaluated...
8.
Khandelwal P, Millard H, Thiel E, Abdel-Azim H, Abraham A, Auletta J, et al.
Biol Blood Marrow Transplant . 2017 Apr; 23(8):1342-1349. PMID: 28450183
This Center for International Blood and Marrow Transplant Research report describes the use of hematopoietic stem cell transplantation (HSCT) in pediatric patients with cancer, 4408 undergoing allogeneic (allo) and3076 undergoing...
9.
OHandley J, Bancalari E, True A, Camitta B, Pisacano N
Postgrad Med . 2016 Jul; 57(6):25. PMID: 27414198
No abstract available.
10.
Asselin B, Devidas M, Chen L, Franco V, Pullen J, Borowitz M, et al.
J Clin Oncol . 2015 Dec; 34(8):854-62. PMID: 26700126
Purpose: To determine the oncologic efficacy, cardioprotective effectiveness, and safety of dexrazoxane added to chemotherapy that included a cumulative doxorubicin dose of 360 mg/m(2) to treat children and adolescents with...